Raoel Maan, Mandy N Lauw, Loise China, David Patch, Anna Baiges, Juan Carlos Garcia-Pagan, Virginia Hernández-Gea, Marie-Noelle Hilleret, Eric T Tjwa, Ilias Kounis, Christophe Bureau, Baptiste Giguet, Alexandra Heurgué, Isabelle Ollivier-Hourmand, Xavier Causse, Filipe Nery, Ahad Eshraghian, Aurélie Plessier, Sarwa Darwish Murad
BACKGROUND AND AIMS: Since the introduction of SARS-CoV-2 vaccines, several cases of vaccine-induced immune thrombocytopenia and thrombosis (VITT) have been described, especially cerebral vein thrombosis. We aimed to retrospectively collect all new cases of acute onset first or recurrent splanchnic vein thrombosis (SVT) following a recent SARS-CoV-2 vaccination within the Vascular Liver Disease Group network. APPROACH AND RESULTS: New cases of SVT were identified from April 2021 to April 2022; follow-up was completed on December 31, 2022...
February 15, 2024: Hepatology: Official Journal of the American Association for the Study of Liver Diseases